ABIO Latest Quarter's Earnings
| Announce Date | 10/28/2022 |
| EPS Normalized Actual | $-0.16 In Line |
| EPS GAAP Actual | $-0.16 In Line |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
Upcoming Quarter's Earnings
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2008 | -13507.2 | -0 | -13507.2 | -13507.2 | 0 |
| Dec 2000 | -17236.8 | -0 | -17236.8 | -17236.8 | 0 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | -121.76 | -123.10259 | 0B | NAN% | 0M |
| FQ2 2025 (Jun 2025) | -38.26 | -38.26 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | -32.95 | -32.95 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.18 | -1.52259 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | 0 | -1.57645 | 0B | NAN% | 0M |
| FQ4 2023 (Dec 2023) | 0.0755 | -2.01291 | 0B | NAN% | 0M |
| FQ1 1997 (Mar 1997) | -6785.71 | -6785.71 | 0.0003B | 100% | 0.3M |
| FQ2 2023 (Jun 2023) | -0.0665 | -0.0665 | 0B | NAN% | 0M |
Quarterly Estimates Summary
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
1
Revenue # of Misses
0
Revenue # of in-lines
7
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | 1.34259 | -121.76 | -123.10259 | 101.1% |
| FQ2 2025 (Jun 2025) | -38.26 | -38.26 | 100% | |
| FQ1 2025 (Mar 2025) | -32.95 | -32.95 | 100% | |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.18 | -1.52259 | 845.88% |
| FQ1 2024 (Mar 2024) | 1.57645 | 0 | -1.57645 | -INF% |
| FQ4 2023 (Dec 2023) | 2.08841 | 0.0755 | -2.01291 | -2666.11% |
| FQ1 1997 (Mar 1997) | -6785.71 | -6785.71 | 100% | |
| FQ2 2023 (Jun 2023) | -0.0665 | -0.0665 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
| FQ1 1997 (Mar 1997) | $0B | $0B | $0.3M | 100% |
| FQ2 2023 (Jun 2023) | $0B | $0B | $0M | NAN% |
ABIO Ratings Summary
ABIO Quant Ranking
